The Radiology Business Journal (4/14, Walter) reports that “the FDA posted a new advisory to its Mammography Quality Standards Act (MQSA) website earlier this week, emphasizing the importance of proper patient positioning during mammography.” According to the advisory, “Poor positioning has been found to be the cause of most clinical image deficiencies and most failures of accreditation.”
HealthDay (4/14, Thompson) reports that a study “suggests that all women turning 40 should get a breast cancer risk assessment, since half of them may have risks that are high enough to warrant annual mammograms right away.” This “review of female patients between the ages of 40 and 44 found that 50 percent had an above-average risk for breast cancer, and therefore would be eligible to begin screening mammography at age 40, said lead researcher Dr. Jennifer Plichta.” The research “also found a significant percentage of women would qualify for other breast screening methods, including breast MRI and genetic testing, Plichta said.” The study was presented at the American Society of Breast Surgeons annual meeting. Aunt Minnie (4/15, Yee) also covers the story.
Aunt Minnie (4/8, Yee) reports that in a presentation at the Society of Breast Imaging show in Austin, TX, Steven Poplack, MD, from Washington University School of Medicine and the Mallinckrodt Institute of Radiology discussed “key considerations to take into account” when incorporating digital breast tomosynthesis (DBT) into a radiology practice. For example, “facilities seeking to implement breast tomosynthesis need to carefully consider which vendor to work with, develop a strategy for integrating the technology into their department’s workflow, and determine how to get the word out to patients and referring physicians that DBT is available.”
Medscape (4/7) reports that the National Comprehensive Cancer Network (NCCN) released updated guidelines for breast cancer adding that “hypofractionation, a shorter course of radiation delivered for 3 weeks instead of 5 weeks, is now preferred over whole-breast radiation.”